BioWorld 24 nov 2025 Bayer’s asundexian hits phase III stroke goal in win for FXIa drugs #phase III #drugs Detailed
BioWorld 24 nov 2025 Novo’s semaglutide fails in phase III Alzheimer’s trials #phase III #III Alzheimer
BioWorld 24 nov 2025 Data back spinal injury bid from Nervgen in phase Ib/IIa #Pharma Corp #Nervgen Pharma
BioWorld 24 nov 2025 CMS finalizes plan to do away with inpatient-only list #Medicaid Services #CMS finalizes
BioWorld 24 nov 2025 New Samyang Holdings, Samsung Biologics spin-offs debut on Kospi #Samyang Holdings #Samsung Biologics
BioWorld 24 nov 2025 Diag-nose.io develops respiratory disease precision diagnostics #Medical Pty #Diag-Nose Medical
BioWorld 24 nov 2025 Appointments and advancements for Nov. 24, 2025 #Galvanize Therapeutics #med-tech industry